Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
531-541
Author(s):
N. M. Mazure, M. C. Brahimi-Horn and J. Pouysségur
Calcium as a Molecular Target in Angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
543-551
Author(s):
Angela M. Patton, Jareer Kassis, Howard Doong and Elise C. Kohn
Small-molecule Inhibitors of Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinases (TK)
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
567-581
Author(s):
Fabrizio Manetti and Maurizio Botta
Thrombospondins as Anti-Angiogenic Therapeutic Agents
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
583-588
Author(s):
Bruno Vailhé and Jean-Jacques Feige
9-Hydroxyellipticine and Derivatives as Chemotherapy Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
67-76
Author(s):
Margaret M. Harding and Annaleise R. Grummitt
Apoptosis in Drug Response
Journal:
Current Pharmacogenomics
Volume:
1
Page:
9-16
Author(s):
Simone Fulda and Klaus-Michael Debatin
Genetic Polymorphism and Tumor Immunotherapy
Journal:
Current Pharmacogenomics
Volume:
1
Page:
37-57
Author(s):
Rongcun Yang and Richard B.S. Roden
Genomic and Proteomic Techniques and their Application in Selenium Research
Journal:
Current Pharmacogenomics
Volume:
1
Page:
59-65
Author(s):
Huawei Zeng
The Genomic Approaches to Major Depression
Journal:
Current Pharmacogenomics
Volume:
1
Page:
67-74
Author(s):
Chen-Jee Hong and Shih-Jen Tsai
The Leukocyte Common Antigen-Related Protein LAR: Candidate PTP for Inhibitory Targeting
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
809-819
Author(s):
Charles M. LeVea and Robert A. Mooney